Lonza at NYSCC Suppliers’ Day: New PreservationPlus™ Approach Provides Preservative Efficacy


Lonza also highlights BioActives to help shield skin from urban lifestyle and environmental stressors; scalp care ingredients for healthy hair and Polyaldo® polygylceryl esters for foamy yet mild cleansing formulations.

South Plainfield, NJ (USA) - 15 May 2018
At At NYSCC Suppliers’ Day, Lonza Consumer Product Ingredients (Booth 1011) will introduce to the U.S. market, PreservationPlus™, the company’s new approach to providing preservative efficacy and developing marketleading formulations through complementary and integrated scientific expertise. Lonza also will launch its new spectrum of bioactive functional ingredients that help protect the skin from modern lifestyle and environmental stressors such as pollution, UV radiation and stress. NYSCC Suppliers’ Day takes place today and May 16 in New York City.

Preservation Beyond Chemistry
The PreservationPlus™ concept responds to customer needs and applies integrated expertise to developing market-leading formulations.

As formulations become more complex to respond to evolving consumer demands, we recommend moving preservative selection upstream in the development process,” said Phil Hindley, Head of Global Marketing, Preservation. “The days of selecting a preservative product or chemistry in isolation have passed.

Hindley emphasized the importance of incorporating strong formulation proficiency from the very start. “We’re wellequipped to help cosmetics manufacturers develop fullyformulated systems in which all components are optimized and synergistic. Our PreservationPlusTM approach helps manufacturers reduce their development costs and their time to market.

Lonza complements its ever-evolving preservation productp ortfolio with superior technical service, regulatory and toxicology expertise, and formulation know-how, all based on science. In addition, all aspects of PreservationPlusTM are designed to align and customize the preservation offer to the complete formulation chemistry.

Lonza bioactives are driven by science. “New studies have generated new data and substantiate new claims,” said Vanessa Arruda, Global Market Development Manager, Bioactives. “Our recent in vitro and ex vivo studies have proven the capabilities of our bioactive portfolio to help protect skin against the stressors of the modern urban lifestyle. We’re pleased to share the results at Suppliers’ Day.”

Bioactive Showcase for skin protection
Lonza is showcasing three bioactives at the event:
  • NAB® Rhodiola extract from the Rhodiola rosea plant, which naturally thrives in harsh conditions. This thermal protectant has been shown to help provide antioxidant protection to skin from external stresses, including UV radiation.
  • LactoPro CLP bioactive, an advanced nutrient moisturizing complex containing Lactobacillus and soybean oil which helps strengthen the skin barrier, enhances skin elasticity, helps retain moisture and leads to healthier, vitalized and more balanced skin.
  • Metabiotics® Resveratrol ECT GEO bioactive, a biotechnological ingredient ideal for cosmetic formulations. It helps improve the radiance and youthfulness of skin by effectively reducing the appearance of fine lines and wrinkles.
Generating Foam, Keeping It Mild
Lonza also will feature its range of versatile Polyaldo® polyglyceryl esters, naturally derived surfactants that are an easily customizable choice for cleansing formulations. A mainstay of the Lonza personal care portfolio, the Polyaldo polyglyceryl esters offer excellent foam generation while maintaining mildness. They are suitable for a variety of international markets; many products are certified Kosher and Halal.

Scalp Care for Healthy Hair
In addition, Lonza is highlighting its scalp care portfolio, which helps formulators create the foundation for healthy hair.

Healthy hair begins with a healthy scalp, and each of the four ingredients Lonza is highlighting at Suppliers’ Day performs a different function to support scalp health,” said
Laura Szymczak, Associate Director, Regional Personal Care Marketing. "We’ve applied benefits for skin to the scalp, and new data substantiates new claims for each ingredient.
  • Carnipure® Carnitine keeps the scalp fresh by exfoliating and moisturizing the skin barrier.
  • LactoPro CLP, a scalp macronutrient complex including Lactobacillus, milk solids and soybean oil, helps improve scalp health by retaining existing moisture and building the scalp barrier.
  • NAB® Butterbur extract is designed for formulations for sensitive skin and can also help soothe an irritated scalp.
  • NAB® Rhodiola extract in scalp-care formulations delivers triple protection for the scalp: detoxification via antioxidants that limit the ability of free radicals to damage skin cells; protection against hot and cold thermal stress; and calming scalp irritation.

About Lonza
Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. As an integrated solutions provider, Lonza is boosting its value creation along and beyond the healthcare continuum with a strong focus on patient healthcare, consumer preventive healthcare and consumer’s healthy environment.

Lonza harnesses science and technology to create products that support safer and healthier living and that enhance the overall quality of life. With the recent Capsugel acquisition, Lonza now offers products and services from the custom development and manufacturing of active pharmaceutical ingredients to innovative dosage forms for the pharma and consumer health and nutrition industries.

Benefiting from its regulatory expertise, Lonza is able to transfer its know-how from pharma to hygiene and fastmoving consumer goods all the way to coatings and composites and the preservation and protection  ofagricultural goods and other natural resources.

Founded in 1897 in the Swiss Alps, Lonza today is a wellrespected global company with more than 100 sites and offices and approximately 14,500 full-time employees worldwide. The company generated sales of CHF 5.1 billion in 2017 with a CORE EBITDA of CHF 1.3 billion.

Further information can be found at

« back